Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Lowering opioid use before spine surgery

Official title: A Pilot Study of the Feasibility of Preoperative Opioid Tapering Before Spine Surgery Using Cognitive Behavioral Therapy and Measuring Postoperative Outcomes

Run by Thomas Jefferson University · NCT07221786 · Data updated 2026-11-12

This pilot test tries two tapering approaches for adults who take daily opioids and have spine surgery scheduled at least four weeks away—education alone versus education plus two CBT sessions—to see which helps them reduce opioids by the time of surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorThomas Jefferson University
Academic / other
Locations1 site (Philadephia, Pennsylvania)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2026
Study endsDecember 2026
Registry record updatedMarch 24, 2026
Trial IDNCT07221786 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for major spine surgery at least four weeks in advance who take 40–200 oral morphine milligram equivalents per day and can complete telemedicine visits are ideal candidates.

Probably not a fit

Patients who are non-English-speaking, unable to use a computer or tablet, unable to complete assessments, or who screen positive on the Columbia Suicide Severity Rating Scale are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized pilot will enroll 45 adults taking 40–200 oral morphine milligram equivalents daily who are scheduled for major spine surgery at least four weeks in advance. Participants are assigned to personalized opioid tapering with education alone or to the same tapering plus two preoperative cognitive behavioral therapy (CBT) sessions, with pain physicians designing individual taper plans. Pain, opioid withdrawal, depression, and anxiety are monitored during the month prior to surgery and throughout hospitalization, and opioid use at the time of surgery is the primary outcome. Additional hospital outcomes, including postoperative pain, opioid requirements, complications, and length of stay, will also be recorded.

Why it matters

Potential benefit: If successful, this approach could help patients lower opioid use before spine surgery and reduce postoperative opioid exposure and related complications.

How similar studies have gone: Behavioral interventions and preoperative tapering have shown promise in observational and small studies, but randomized evidence comparing education alone versus CBT-enhanced tapering before spine surgery is limited, making this pilot relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* at least 18 years old
* scheduled for major spine surgery (i.e. at least 1 level of fusion) with hospital admission of at least one night
* scheduled for spine surgery at least 4 weeks ahead of time
* takes between 40 and 200 oral morphine equivalents daily

Exclusion:

* inability to use a computer or tablet for telemedicine encounters
* non-English-speaking
* inability to complete assessments
* positive screen on the Columbia Suicide Screening Assessment

Where it's running

  • Thomas Jefferson University Hospital
    Philadephia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.